AKT1 and cancer: In addition to anti-cancer activities, GL can modulate oncogenic signaling pathways, such as the PI3K/Akt/mTOR and JAK/STAT5 in cancer (Weng and Yen, 2010; Gill and NavgeetKumar, 2017; Jin et al., 2020).